Professional Documents
Culture Documents
Can stem cells from multiple donors be combined for use in a single transplant?
Finding two stem cell units that are a match for the patient is much more difficult than finding one. Using multiple cord blood transplants is another approach that has been studied for some time.
Who should save placental and umbilical cord blood stem cells?
While everyone should consider saving their newborns stem cells, some groups should give it even more consideration.
Saving stem cells is a prudent choice if you or your spouse/partner have a family history of a disease that is treatable with stem cells, such as leukemia, lymphoma, or myeloma. Ethnic minorities and families of mixed ethnicity should consider saving stem cells because these groups have greater difficulty finding stem cell donors when needed. Many genetic diseases such as sickle cell anemia and thalassemia are more common in certain ethnic populations. Both of these diseases have been successfully treated with stem cells. Families preparing to adopt a newborn should consider saving stem cells since, if they are ever needed, the cord blood and placenta stem cells may be the only available genetic source of stem cells for the adopted baby. In addition, depending upon the terms of the adoption, complete family medical histories may not be available and stem cells might provide valuable medical information for the purposes of personalized medicine. Couples using fertility treatments that involve a donor egg and/or sperm should consider saving stem cells because this may be the only opportunity to secure a genetically related sample of stem cells for their child.
Who should save cord tissue and placenta tissue stem cells?
Parents-to-be who want to expand their babys options for future medical treatment should consider banking stem cells from their babys cord tissue and placenta tissue. The physical tissue of the umbilical cord and the physical tissue of the placenta (not to be confused with cord blood drained from the umbilical cord and placenta) contain mesenchymal stem cells (MSCs). MSCs are a different type of stem cell than those collected from cord blood in the umbilical cord and placenta. While MSCs are not currently being used for medical therapies, they are the subject of over 200 clinical trials. Research has indicated that MSCs hold the promise of being able to someday treat debilitating conditions such as heart disease, type 1 diabetes, lung cancer, Parkinsons Disease, and injuries to bones and cartilage.